28 Day Repeat Dose in Cystic Fibrosis Patients

Clinical trial NCT00903201 · COMPLETED

Trial details

NCT number: NCT00903201
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2009-09-28
Primary completion: 2010-12-29
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.